Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host translation factors are proteins in eukaryotic cells that facilitate the multi-step process of protein synthesis (translation) by aiding the initiation, elongation, and termination of mRNA-directed polypeptide chain formation[3][5][9]. The primary families include initiation factors (eIFs), elongation factors (eEFs), and release/termination factors (eRFs), each with multiple subtypes and roles[7]. These factors are essential for normal gene expression, cell viability, and response to environmental stimuli. Because viruses rely on host translation factors to synthesize their own proteins, various viral proteins specifically inhibit or hijack host translation factors to subvert cellular machinery and promote infection[1][2][7]. Certain translation factors are studied as potential therapeutic targets in cancer and infectious diseases, but broad-spectrum inhibition leads to major safety challenges, given the essential, non-redundant function of these proteins in all cells.
Inhibition of translation initiation or elongation, usually by binding to or inactivating specific translation factors such as eIF4A or the ribosome[1][5][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host translation factor.